Cancer patients urge rethink over treatment
Six years ago Abiraterone was hailed as a medical breakthrough that could offer men extra time with loved ones and a chance to delay chemotherapy and its debilitating side effects. But today the body that recommends what can and cant be paid for said it 'wasn't cost effective'.